STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] Natera, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Natera, Inc. (NTRA) filed a Form 144 indicating that insider Gail Marcus intends to sell up to 2,496 common shares through Merrill Lynch on or after 1 Aug 2025. The proposed sale is valued at $332,394.72, based on the market price at the time of filing. Natera has 136.55 million shares outstanding, so the planned sale equals <0.01 % of the float.

The shares were acquired via equity-compensation grants on 9 Jun 2024 (2,374 sh) and 26 Jul 2024 (122 sh). Marcus has already sold 12,299 shares over the past three months, generating gross proceeds of ≈$1.98 million (4,000 sh on 1 May 2025, 4,000 sh on 10 Jun 2025, 4,299 sh on 1 Jul 2025).

While the filing signals continued insider selling, the absolute volume remains immaterial relative to total shares and does not, by itself, imply a change in the company’s fundamentals.

Positive

  • None.

Negative

  • Continued insider selling may be interpreted as a modest sentiment headwind, though size is immaterial.

Insights

TL;DR: Small insider sale (2,496 sh) follows prior 12,299 sh sold; percentage of float negligible, so market impact likely muted.

The Form 144 reveals incremental selling by Gail Marcus, adding to roughly $2 million of prior sales this quarter. Even when combined, her disposals amount to <0.02 % of Natera’s 136.5 million outstanding shares—well below typical insider-signal thresholds. The shares were acquired via routine equity compensation, suggesting profit-taking rather than a strategic exit. No adverse operational information is disclosed. Given the minimal size and absence of other catalysts, I view this filing as neutral for valuation and liquidity.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many NTRA shares does Gail Marcus plan to sell under this Form 144?

2,496 common shares are slated for sale.

What is the expected market value of the proposed sale?

The filing lists an aggregate value of $332,394.72.

When can the shares be sold?

The approximate sale date disclosed is August 1, 2025.

How many Natera shares has the filer sold in the last three months?

Marcus sold 12,299 shares between May and July 2025, grossing about $1.98 million.

What proportion of Natera’s outstanding shares does this sale represent?

The 2,496 shares equal <0.01 % of the 136.55 million shares outstanding.
Natera Inc

NASDAQ:NTRA

NTRA Rankings

NTRA Latest News

NTRA Latest SEC Filings

NTRA Stock Data

32.73B
133.33M
3.2%
96.35%
2.7%
Diagnostics & Research
Services-medical Laboratories
Link
United States
AUSTIN